
Acumetis CEO Herspiegel steps down as Burden assumes role
pharmafile | October 27, 2026 | Appointment | |Â Â Appointments Corporate, CorporateÂ
Ramil Burden is the new Chief Executive Officer of Acumetis, announced the company in a recent statement.
Founder and CEO Brent Herspiegel will retire from the CEO role and continue serving on the company’s Board of Directors, helping ensure a seamless transition and supporting the company’s long-term success.
Related Content
No items found






